YCS23· AIOlio Labs
Combination therapeutics for the world's toughest diseases
Founders
Not read from YC yet; the weekly run fills these in.
Same space
Adjacent
Overlapping tags, a different niche.
Harmonic DiscoveryS21Multi-targeted therapeutics to treat complex diseasesShared: therapeutic, disease, proteinActive
OriginW26AI and Data for Cancer TherapeuticsShared: therapeutic, effect, drugActive
Rosebud BiosciencesW22Growing micro-organs to find new drugsShared: therapeutic, disease, targetActive
Equator TherapeuticsW20We are developing a drug to burn calories and increase metabolism…Shared: therapeutic, obesity, effectActive
Serinus BiosciencesS22Combinations therapy by rational designShared: combination, toughestActive
Also from S23 in AI
Batchmates in Summer 2023.
AccendS23AI agents for commercial underwriting at banks and fintechsActive
AgentCollectS23B2B debt collection powered by AI agentsActive
AglideS23Connect every disconnected app to your SSO.Active
AirgoodsS23The modern distributor for grocers.Active
AiSDRS23AI that finds the right buyers and books sales meetingsActive
AlgunaS23AI-Native CPQ & Billing for Modern Pricing ModelsActive
About Olio Labs
Olio labs uses AI to develop combination therapeutics that consider the thousands of interacting proteins in your body rather than targeting just one or two. Their lead combinations target obesity and are more effective with fewer side effects than Ozempic, the fastest growing drug of all time. Their custom ML built from real-world expertise and cutting edge AI searches trillions of combinations to find the perfect one.
Remote
Olio Labs: questions
Which YC batch was Olio Labs in?
Olio Labs was in Y Combinator's Summer 2023 batch (S23).
Is Olio Labs still active?
Y Combinator lists Olio Labs as active.
Where is Olio Labs based?
Olio Labs lists Remote as its location on YC's directory.
Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.